Table 3 Standardized incidence ratios and standardized mortality ratios
Tumor type | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|
(ICD-10) | Observed | SIR | SMR | Observed | SIR | SMR | ||
Incidence | Mortality | (95% CI) | (95% CI) | Incidence | Mortality | (95% CI) | (95% CI) | |
Lung (C33–34) | 83 | 87 | 1.16 (0.94–1.44) | 1.09 (0.89–1.35) | 11 | 14 | 0.42 (0.21–0.76) | 0.53 (0.29–0.89) |
Colorectal (C17–21) | 29 | 16 | 0.50 (0.34–0.72) | 0.52 (0.30–0.85) | 49 | 27 | 0.92 (0.68–1.22) | 0.91 (0.60–1.33) |
Breast (C50) | 92 | 27 | 0.80 (0.65–0.98) | 0.63 (0.42–0.93) | ||||
Prostate (C61) | 53 | 6 | 0.75 (0.57–0.98) | 0.30 (0.11–0.65) | ||||
Malignant melanoma (C43) | 9 | 2 | 0.89 (0.41–1.69) | 0.73 (0.09–2.64) | 12 | 2 | 1.00 (0.52–1.76) | 0.86 (0.10–3.11) |
Stomach (C16) | 36 | 26 | 2.22 (1.55–3.07) | 1.91 (1.25–2.81) | 29 | 24 | 2.32 (1.56–3.35) | 2.15 (1.38–3.18) |